d-Cycloserine attenuates reactivity to smoking cues in nicotine dependent smokers: A pilot investigation

Drug and Alcohol Dependence

Volumn 104, Issue 3, 2009, Pages 220-227

  Santa Ana, Elizabeth J ^a,b   Rounsaville, Bruce J ^a,b   Frankforter, Tami L ^b   Nich, Charla ^b   Babuscio, Theresa ^b   Poling, James ^a,b   Gonsai, Kishorchandra ^a,b   Hill, Kevin P ^b   Carroll, Kathleen M ^a,b  

^a VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cue exposure; Cue exposure therapy; d Cycloserine; Nicotine addiction; Smoking cue reactivity; Smoking cues

Indexed keywords

CARBON MONOXIDE; CYCLOSERINE; PLACEBO;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG RESPONSE; FEMALE; HUMAN; MALE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; TOBACCO DEPENDENCE;

ADULT; BEHAVIOR, ADDICTIVE; BREATH TESTS; CARBON MONOXIDE; COMBINED MODALITY THERAPY; COTININE; CUES; CYCLOSERINE; DOUBLE-BLIND METHOD; EXTINCTION, PSYCHOLOGICAL; FEMALE; GALVANIC SKIN RESPONSE; HUMANS; MALE; PILOT PROJECTS; PSYCHOTHERAPY; TOBACCO USE DISORDER;

ANIMALIA;

EID: 68349160824     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2009.04.023     Document Type: Article

References (55)

1. Abrams D.B., Monti P.M., Carey K.B., Pinto R.P., and Jacobus S.I. Reactivity to smoking cues and relapse: two studies of discriminant validity. Behav. Res. Ther. 26 (1988) 225-233
2. Abrams D.B., Niaura R., Brown R.A., Emmons K.M., Goldstein M.G., and Monti P.M. The Tobacco Dependence Treatment Handbook: A Guide to Best Practices (2003), The Guilford Press, New York
3. Benowitz N.L., Jacob P., Ahijevych K., Jarvis M.J., Hall S., LeHouezec J., Hansson A., Lichtenstein E., Henningfield J., Tsoh J., Hurt R.D., and Velicer W. Biochemical verification of tobacco use and cessation. Nicotine Tob. Res. 4 (2002) 149-159
4. Benowitz N.L., and Jacob III P. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin. Pharmacol. Ther. 34 (1994) 604-611
5. Brandon T.H., Piasecki T.M., Quinn E.P., and Baker T.B. Cue exposure treatment in nicotine dependence. In: Drummond D.C., Tiffany S.T., Glautier S., and Remington B. (Eds). Addictive Behavior: Cue Exposure Theory and Practice (1995), Wiley, New York
6. Botreau F., Paolone G., and Stewart J. d-Cycloserine facilitates extinction of a cocaine-induced conditioned place preference. Behav. Brain Res. 172 (2006) 173-178
7. Bryk A.S., and Raudenbush S.W. Application of hierarchical linear models to assessing change. Psychol. Bull. 101 (1987) 147-158
8. Caggiula A.R., Donny E.C., White A.R., Chaudhri N., Booth S., Gharib M.A., Hoffman A., Perkins K.A., and Sved A.F. Cue dependency of nicotine self-administration and smoking. Pharmacol. Biochem. Behav. 70 (2001) 515-530
9. Caggiula A.R., Donny E.C., Chaudhri N., Perkins K.A., Evans-Martin F.F., and Sved A.F. Importance of nonpharmacological factors in nicotine self-administration. Physiol. Behav. 77 (2002) 683-687
10. Cautela J.R., and Kearney A.J. The Covert Conditioning Handbook (1986), Springer, New York
11. Carroll K.M., Fenton L.R., Ball S.A., Nich C., Frankforter T.L., Shi J., and Rounsaville B.J. Efficacy of disulfiram and cognitive behavior therapy in cocaine-dependent outpatients: a randomized placebo-controlled trial. Arch. Gen. Psychiatry 61 (2004) 264-272
12. Conklin C.A., and Tiffany S.T. Applying extinction research and theory to cue-exposure addiction treatments. Addiction 97 (2002) 155-167
13. Cox L.S., Tiffany S.T., and Christen A.G. Evaluation of the brief questionnaire of smoking urges (QSU-brief) in laboratory and clinical settings. Nicotine Tob. Res. 3 (2001) 7-16
14. Davis M., and Meyers K.M. The role of glutamate and gamma-aminobutyric acid in fear extinction: clinical implications for exposure therapy. Biol. Psychiatry 52 (2002) 998-1007
15. Davis M., Ressler K., Rothbaum B.O., and Richardson R. Effects of d-cycloserine on extinction: translation from preclinical to clinical work. Biol. Psychiatry 60 (2006) 369-375
16. Drobes D., and Tiffany S. Induction of smoking urge through imaginal and in vivo procedures: physiological and self-report manifestations. J. Abnorm. Psychol. 106 (1997) 15-25
17. Drummond D.C., Tiffany S.T., Glautier S., and Remington B. Cue exposure in understanding and treating addictive behavior. In: Drummond D.C., Tiffany S.T., Glautier S., and Remington B. (Eds). Addictive Behaviors: Cue Exposure Theory and Practice (1995), John Wiley & Sons, London 1-17
18. Fals-Stewart W., O'Farrell T.J., Freitas T.T., McFarlin S.K., and Rutigliano P. The timeline followback reports of psychoactive substance use by drug-abusing patients: psychometric properties. J. Consult. Clin. Psychol. 68 (2000) 134-144
19. Field M., and Duka T. Cue reactivity in smokers: the effects of perceived cigarette availability and gender. Pharmacol. Biochem. Behav. 78 (2004) 647-652
20. Fiore M.C., Jaén C.R., Baker T.B., Bailey W.C., Benowitz N.L., Curry S.J., Dorfman S.F., Froelicher E.S., Goldstein M.G., Healton C.G., Henderson P.N., Heyman R.B., Koh H.K., Kottke T.E., Lando H.A., Mecklenburg R.E., Mermelstein R.J., Mullen P.D., Orleans C.T., Robinson L., Stitzer M.L., Tommasello A.C., Villejo L., Wewers M.E., Murray E.W., Bennett G., Heishman S., Husten C., Morgan G., Williams C., Christiansen B.A., Piper M.E., Hasselblad V., Fraser D., Theobald W., Connell M., and Leitzke C. Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline (2008), U.S. Department of Health and Human Services, Public Health Service, Rockville, MD
21. Fowles D.C., Christie M.J., Edelberg R., Grings W.W., Lykken D.T., and Venables P.H. Publication recommendations for electrodermal measurements. Psychophysiology 18 (1981) 232-239
22. Gariti P., Alterman A.I., Ehrman R., Mulvaney F.D., and O'Brien C.P. Detecting smoking following smoking cessation treatment. Drug Alcohol Depend. 65 (2002) 191-196
23. Hammersley R. Cue exposure and learning theory. Addict. Behav. 17 (1992) 297-300
24. Havermans R.C., and Jansen A.T.M. Increasing the efficacy of cue exposure treatment in preventing relapse of addictive behavior. Addict. Behav. 28 (2003) 989-994
25. Heather N.B., and Bradley P. Cue exposure as a practical treatment for addictive disorders: why are we waiting?. Addict. Behav. 15 (1990) 335-337
26. Heatherton T., Kozlowski L., Frecker R., and Fagerström K.O. The Fagerström test for nicotine dependence: a revision of the Fagerström Tolerance Questionnaire. Br. J. Addict. 86 (1991) 1119-1127
27. Hofmann S.G., Meuret A.E., Smits J.A., Simon N.M., Pollack M.H., Eisenmenger K., Shickh M., and Otto M.V. Augmentation of exposure therapy with d-cycloserine for social anxiety disorder. Arch. Gen. Psychiatry 63 (2006) 298-304
28. Kushner M.G., Kim S.W., Donahue C., Thuras P., Adson D., Kotlyar M., McCabe J., Peterson J., and Foa E.B. d-Cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol. Psychiatry 62 (2007) 835-838
29. Ledgerwood L., Richardson R., and Cranney J. d-Cycloserine facilitates extinction of conditioned fear as assessed by freezing in rats. Behav. Neurosci. 117 (2003) 341-349
30. Marlatt G.A. Cue exposure and relapse prevention in the treatment of addictive behaviors. Addict. Behav. 15 (1990) 395-399
31. Miller W.R., and Rollnick S. Motivational Interviewing: Preparing People for Change vol. 2 (2002), Guilford Press, New York
32. Min Z., Nix D.E., Adam R.D., Chjlds J.M., and Peloquin C.A. Pharmacokinetics of cycloserine under fasting conditions and with high-fat meal, orange juice, and antacids. Pharmacotherapy 21 (2001) 891-897
33. Monti P.M., Rohsenow D.J., Rubonis A.V., Niaura R.S., Sirota A., Colby S.M., Goddard P., and Abrams D.B. Cue exposure with coping skills treatment for male alcoholics: a preliminary investigation. J. Consult. Clin. Psychol. 61 (1993) 1011-1019
34. Myers K.M., and Davis M. Behavioral and neural analysis of extinction. Neuron 36 (2002) 567-584
35. Niaura R., Abrams D.B., Shadel W.G., Rohsenow D.J., Monti P.M., and Sirota A.D. Cue exposure treatment for smoking relapse prevention: a controlled clinical trial. Addiction 94 (1999) 685-695
36. Niaura R.S., Rohsenow D.J., Binkoff J.A., Monti P.M., Pedraza M., and Abrams D.B. Relevance of cue reactivity to understanding alcohol and smoking relapse. J. Abnorm. Psychol. 2 (1988) 133-152
37. Niaura R., Shadel W.G., Abrams D.B., Monti P.M., Rohsenow D.J., and Sirota A. Individual differences in cue reactivity among smokers trying to quit: Effects of gender and cue type. Addict. Behav. 23 (1998) 209-224
38. O'Brien C.P., Childress A.R., McLellan T., and Ehrman R. Integrating systematic cue exposure with standard treatment in recovering drug dependent patients. Addict. Behav. 15 (1990) 355-365
39. Perkins K.A., Epstein L.H., Grobe J., and Fonte C. Tobacco abstinence, smoking cues, and the reinforcing value of smoking. Pharmcol. Biochem. Behav. 47 (1994) 107-112
40. Perkins K.A., Doyle T., Ciccocioppo M., Conklin C., Sayett M., and Caggiula A. Sex differences in the influence of nicotine dose instructions on the reinforcing and self-reported rewarding effects of smoking. Psychopharmacology 184 (2006) 600-607
41. Perkins K.A., Gerlach D., Vender J., Grobe J., Meeker J., and Hutchison S. Sex differences in the subjective and reinforcing effects of visual and olfactory cigarette smoke stimuli. Nicotine Tob. Res. 3 (2001) 141-150
42. Piasecki T.M., and Baker T.B. Any further progress in smoking cessation treatment?. Nicotine Tob. Res. 3 (2001) 311-323
43. Ressler K.J., Rothbaum B.O., Tannenbaum L., Anderson P., Graap K., Zimand E., Hodges L., and Davis M. Cognitive enhancers as adjuncts to psychotherapy. Use of d-cycloserine in phobic individuals to facilitate extinction of fear. Arch. Gen. Psychiatry 61 (2004) 1136-1144
44. Rioult-Pedotti M.S., Friedman D., and Donoghue J.P. Learning-induced LTP in neocortex. Science 290 (2000) 533-536
45. Rose J.E., and Behm F.M. Extinguishing the rewarding value of smoke cues: pharmacological and behavioral treatments. Nicotine Tob. Res. 6 (2004) 523-532
46. Santini E., Muller R.U., and Quirk G.J. Consolidation of extinction learning involves transfer from NMDA-independent to NMDA-dependent memory. J. Neurosci. 21 (2001) 9009-9017
47. Sobell L.C., and Sobell M.B. Timeline follow-back: a technique for assessing self-reported alcohol consumption. In: Litten R.Z., and Allen J. (Eds). Measuring Alcohol Consumption: Psychosocial and Biological Methods (1992), Humana, New Jersey 41-72
48. Sayette M.A., and Hufford M.R. Effects of cue exposure and deprivation on cognitive resources in smokers. J. Abnorm. Psychol. 103 (1994) 812-818
49. Toll B.A., Katulak N.A., and McKee S.A. Investigating the factor structure of the questionnaire on smoking urges-brief (QSU-brief). Addict. Behav. 31 (2006) 1231-1239
50. Tong C., Bovbjerg D.H., and Erblich J. Smoking-related videos for use in cue-induced craving paradigms. Addict. Behav. 32 (2007) 3034-3044
51. Vervliet B. Learning and memory in conditioned fear extinction: Effects of d-cycloserine. Acta Psychol. 127 (2008) 601-613
52. Watanabe M., Inoue Y., Sakimura K., and Masayoshi M. Developmental changes in distribution of NMDA receptor channel subunit mRNAs. Dev. Neurosci. 3 (1992) 1138-1140
53. Walker D.L., Ressler K.J., Lu K.-T., and Davis M. Facilitation of conditioned fear extinction by systematic administration or intra-amygdala infusions of d-cycloserine as assessed with fear-potentiated startle in rats. J. Neurosci. 22 (2002) 2343-2351
54. Wilhelm S., Buhlmann U., Tolin D.F., Meunier S.A., Pearlson G.D., Reese H.E., Cannistraro P., Jenike M.A., and Rauch S.L. Augmentation of behavior therapy with d-cycloserine for obsessive-compulsive disorder. Am. J. Psychiatry 165 (2008) 335-341
55. Wynd C.A. Guided health imagery for smoking cessation and long-term abstinence. J. Nurs. Scholarsh. 3rd Quarter (2005) 245-250